U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060976) titled 'To Check Dermatological Safety of Test Products by 24 Hours Patch Testing' on July 02.
Brief Summary: To Check Dermatological Safety of Test Products by 24 Hours Patch Testing
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
OTHER: 18 Transdermal patches along with positive and negative controls 1)Capsaicin0.025% Topical Patch, 2)Diclofenac Diethylamine 100mg Transdermal Patch, 3)Diclofenac Diethylamine 200mg Transdermal Patch,
Dose: 1x1 cm of each Patch (1 cm2) Route of administration: Topical Mode of usage: Products will be evaluated through the complete occlusion for 24 hou...